Finance

Lists
OTLK:NASDAQ
Outlook Therapeutics Inc
US$ ०.५८
-१.९५%
(-०.०१२) 1D
अक्टोबर ६, १०:३९:३० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OTLK...
Open
US$ ०.६०
High
US$ ०.६२
Low
US$ ०.५८
Mkt. cap
१४.०५ करोड
Avg. vol.
५६.४४ लाख
Volume
९.६० लाख
52-wk high
US$ २.५४
52-wk low
US$ ०.१६
EPS
-US$ ०.८७
Beta
०.६६
Shares outstanding
२४.३४ करोड
No. of employees
१७
Open
US$ ०.६०
High
US$ ०.६२
Low
US$ ०.५८
Mkt. cap
१४.०५ करोड
Avg. vol.
५६.४४ लाख
Volume
९.६० लाख
52-wk high
US$ २.५४
52-wk low
US$ ०.१६
EPS
-US$ ०.८७
Beta
०.६६
Shares outstanding
२४.३४ करोड
No. of employees
१७
News stories
From web sources and news partners
About Outlook Therapeutics Inc
CEO-
Employees१७
Founded२०१०
Headquarters-
Sector-
Websiteoutlooktherapeutics.com
Analyst ratings
Based on 3 analysts giving stock ratings to OTLK in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for OTLK in the last 3 months.
Highest
Current US$ ०.५८
US$ १०.५० (+१,६९८.२५%)
Average
US$ ५.३७ (+८१९.६८%)
Lowest
US$ १.६० (+१७४.०२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
US$ १०.५०
+१,६९८.३%
09/10/2026
Julian Harrison
BTIG
Buy
Reiterated
US$ ४.००
+५८५%
08/14/2026
Douglas Tsao
H.C. Wainwright
Hold
Reiterated
US$ १.६०
+१७४%
07/28/2026
Daniil Gataulin
Chardan Capital
Hold
Maintained
US$ १.००
+७१.३%
01/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-९१.७९ हजार
-१२.०८ लाख
१.२७ लाख
८.७० हजार
Cost of goods sold
९.१७ लाख
२९.६३ हजार
१.४९ लाख
१६.९६ हजार
Cost of revenue
९.१७ लाख
२९.६३ हजार
१.४९ लाख
१६.९६ हजार
Research and development expenses
५९.७९ लाख
३६.३४ लाख
४५.०१ लाख
३२.५१ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.०३ करोड
८६.१२ लाख
९५.०५ लाख
७५.५१ लाख
Operating expense
१.६३ करोड
१.२२ करोड
१.४० करोड
१.०८ करोड
Total operating expenses
१.७२ करोड
१.२३ करोड
१.४२ करोड
१.०८ करोड
Operating income
-१.७३ करोड
-१.३५ करोड
-१.४० करोड
-१.०८ करोड
Other non operating income
३०.१८ लाख
-२७.९२ लाख
६८.३८ लाख
-७०.३६ लाख
EBT including unusual items
-१.४८ करोड
-२.३१ करोड
-४४.५३ लाख
-२.०३ करोड
EBT excluding unusual items
-१.४५ करोड
-१.६३ करोड
-७२.३४ लाख
-१.७९ करोड
Income tax expense
-१५.५५ लाख
-
-
-
Effective tax rate
१०.४७%
-
-
-
Other operating expenses
-
-
-
-
Net income
-१.३३ करोड
-२.३१ करोड
-४४.५३ लाख
-२.०३ करोड
Net profit margin
१४,४८२.१९%
१,९०९.०५%
-३,४९४.२८%
-२,३३,५५४.८५%
Earnings per share
-०.२९
-०.२२
-०.१७
-०.०९
Interest and investment income
८९.७४ हजार
-
३.००
७.००
Interest expense
-२.६४ लाख
-
-
-
Net interest expenses
-१.७४ लाख
-
३.००
७.००
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.७३ करोड
-१.३५ करोड
-१.४० करोड
-१.०८ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू